ea0038p160 | Neoplasia, cancer and late effects | SFEBES2015
Wanigasekara Nipuni E Wanniachchi
, Bech Paul
, Murphy Kevin
Neuroendocrine tumours (NETs) are rare tumours that originate from neuroendocrine cells and their incidence has increased for the last 20 decades; partly because of advances in diagnostic tools, which have improved detection rates. Chromogranin A (CgA) is the most widely used biochemical tumour marker for NETs, however, its prognostic utility has been questioned due to several non-neuroendocrine causes of elevated CgA. This is the first study to assess the prognostic utility o...